Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 19;9(8):1321–1331. doi: 10.1002/acn3.51628

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

(A) Proportions of positive SARS‐CoV2 antibodies after vaccination in healthy controls (HC) as compared to patients with MS (PwMS). (B) Proportions of positive SARS‐CoV2 antibodies after vaccination in PwMS by type of DMT (disease‐modifying therapy), including interferon‐beta (IFN), glatiramer acetate (GA), dimethyl fumarate/diroximel fumarate (DMF), cladribine (CdA), teriflunomide (TER), natalizumab (NTZ), alemtuzumab (ALZ), sphingosine‐1 phosphate modulators (S1PM), and anti‐CD20 monoclonal antibodies (CD20).